D-0010-2021 Class II Terminated
FDA drug recall D-0010-2021 was initiated by Calvin Scott & Company, Inc. on Sep 16, 2020 and is designated Class II. Reason for recall: cMGP Deviations: Drug products repackaged into pouches without supporting stability studies. The recall status is terminated (terminated Apr 22, 2024).
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 14, 2020
- Initiation Date
- Sep 16, 2020
- Termination Date
- Apr 22, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
Product Description
Diethylpropion, 75 mg tablets, Rx only, Distributed by: Calvin Scott & Co. Inc. Albuquerque, NM 87123; MFG. Lannett Company, Philadelphia, PA 19136, NDC 00527-1477-01
Reason for Recall
cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
Distribution Pattern
Repacked drug products distributed to 12 physician consignees located in the following states: CA, ID, IL,OK, RI
Code Information
Lot #: CS19192, CS19226, CS19263, Exp 10/20; CS19300, Exp 7/21; CS19338, Exp 8/21; CS20034, Exp 10/21; CS20077, Exp 1/22, CS20165, CS20241, Exp 4/22
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0010-2021
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026